Valerie Pierce - 03 Mar 2022 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
SVP, GC & CCO
Signature
/s/ Valerie Pierce
Issuer symbol
NGM
Transactions as of
03 Mar 2022
Transactions value $
$0
Form type
4
Filing time
04 Mar 2022, 15:08:13
Next filing
06 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGM Stock Option (Right to Buy) Award $0 +150K $0.00 150K 03 Mar 2022 Common Stock 150K $15.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest over a four-year period commencing January 1, 2022, with 1/48th of the shares vesting on a monthly basis.